stock market results for today

Apple is getting into the smart speaker market with the HomePod, the company’s first entirely new product in three years. It’s a relatively young hardware category made popular by the Amazon Echo.

Now, more tech companies are rushing out their own versions of the device. You’ve probably heard about talking speakers, but perhaps you’ve wondered how they work and what they mean for your privacy.

Here’s everything you need to know about tech’s hottest new gadgets.

What is a smart speaker?

A smart speaker is a small Wi-Fi connected speaker controlled with voice commands. To use the hands-free device, you speak a trigger phrase “Hey Siri,” “OK Google,” “Alexa” and then ask a question such as “what’s the weather?” or make a request like “order a Lyft.” The speakers are powered by smart assistants like Siri and Alexa that talk back.

What is it used for?

A smart speaker is primarily used to stream music and news, set timers and reminders, manage shopping lists, and control connected-home devices like lights or thermostats. Amazon recently added message and call options, so the speakers will likely be used even more for communication in the future. The Echo is handy for ordering things from Amazon Prime, but it struggles with answering basic knowledge questions. Meanwhile, the Google Home, unsurprisingly, is great for Googling things.

stock market results for today: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

stock market results for today: Unifirst Corporation(UNF)

Advisors’ Opinion:

  • [By Monica Gerson]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    AeroVironment, Inc. (NASDAQ: AVAV) posted upbeat earnings for its fourth quarter, but the company missed analysts’ sales expectations. AeroVironment shares dipped 7.37 percent to $26.40 in the after-hours trading session.
    Analysts are expecting Acuity Brands, Inc. (NYSE: AYI) to have earned $2.03 per share on revenue of $847.79 million in the latest quarter. Acuity Brands shares rose 0.04 percent to $244.75 in after-hours trading.
    CalAmp Corp. (NASDAQ: CAMP) reported stronger-than-expected results for its first quarter and reported a $25 million buyback plan. The company also issued a weak sales forecast for the current quarter. CalAmp shares gained 0.35 percent to $14.14 in the after-hours trading session.
    UniFirst Corp (NYSE: UNF) is expected to report its quarterly earnings at $1.34 per share on revenue of $366.28 million. UniFirst shares slipped 0.72 percent to close at $105.44 on Tuesday.
    A Schulman Inc (NASDAQ: SHLM) reported better-than-expected earnings for its third quarter. A Schulman shares rose 1.61 percent to $21.51 in the after-hours trading session.

    Posted-In: Stocks To WatchEarnings News Guidance Pre-Market Outlook Markets Trading Ideas

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

  • [By Monica Gerson]

    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.26 per share on revenue of $362.62 million.

    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $93.15 million.

stock market results for today: Rovi Corporation(ROVI)

Advisors’ Opinion:

  • [By Emily Stewart]

    Rovi (ROVI) is a new second-quarter acquisition for Soros, who as of the end of the period owns 4.1 million shares worth $63.6 million.

    Rovi is engaged in the discovery, delivery, display and monetization of digital entertainment by providing a broad set of integrated solutions. It has a $1.8 billion market cap. 

stock market results for today: Federated Investors, Inc.(FII)

Advisors’ Opinion:

  • [By Gregg Greenberg]

     Stocks of Federated Investors (FII) fell approximately 9% in 2015, yet Oja expects a big turnaround in 2016, once again due to the prospect of higher rates ahead. 

     

    "The money market fund business, which is unprofitable now, should become more profitable as rates rise because Federated has to reimburse for the servicing fees for these funds," said Oja, who also admires the fund company’s 3.5% dividend yield. 

     

    Oja added that Federated also has a "good core business of equity and fixed-income asset management." 

stock market results for today: Greenhill & Co., Inc.(GHL)

Advisors’ Opinion:

  • [By Jim Robertson]

    For investors with a long memory, the Iridium communications service was launched on November 1, 1998 only for the founding company to go into Chapter 11 bankruptcy nine months later as the cost of service was prohibitive for many users. Iridium Satellite LLC was eventually merged with a special purpose acquisition company (GHQ) created by the investment bank Greenhill & Co. (NYSE: GHL) in September 2009 to form Iridium Communications.

  • [By Lisa Levin]

    In trading on Friday, financial shares slipped by 0.55 percent. Meanwhile, top losers in the sector included Greenhill & Co., Inc. (NYSE: GHL), down 11 percent, and SVB Financial Group (NASDAQ: SIVB), down 8 percent.

stock market results for today: Bayer Aktiengesellschaft (BAYZF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Other R&D products in Regeneron’s pipeline that we are interested in

    Fasinumab: Antibody against nerve growth factor, being developed for pain treatment like osteoarthritis. It is partnered with Teva Pharmaceutical (NASDAQ:TEVA) (for osteoarthritis, in phase 3), and is also being developed for treatment of chronic back pain. It is licensed to Mitsubishi Tanabe for the Japan territory. REGN2222: For prevention of RSV virus infection in infants, competing with Synagis from AstraZeneca (NYSE:AZN). Nesvacumab: Angiopoetin 2 antibody, being tested in combination with Eylea (in phase 2, partnered with Bayer (OTCPK:BAYZF)). Rinucumab (anti-PDGF): Being tested in treatment of wet AMD in combination with Eylea. Phase 2 trial was not successful, but the treatment duration was less (only 12 weeks versus 24 weeks for rival Ophthotech (NASDAQ:OPHT)). 28-week and 52-week data will be released later. With Ophthotech’s phase 3 failure with Fovista, we are bullish on Rinucumab’s commercial potential in wet AMD. Immuno-oncology pipeline: Checkpoint inhibitors and novel CAR-T; still in early stage.

    Click to enlarge

  • [By SEEKINGALPHA.COM]

    Online Direct Sales – Once only consumer electronics and mobile handsets, the products it offers has grown to include 15 different categories, including home appliances and a wide array of general merchandise.

    In April, JD.com became a certified member of the American Apparel & Footwear Association (AAFA), the trusted public policy and political voice of the apparel and footwear industry, a first for a Chinese e-commerce company. In the first quarter of 2017, Avene, the leading demo-cosmetic brand for sensitive skin in European pharmacies, and three brands under Georgio Armani launched flagship stores on JD.com’s direct sales platform. JD Worldwide, a cross-border e-commerce platform set up in April 2015 to provide access to international brands (including those not available in China), has retail contracts with international brands such as Wal-Mart (NYSE:WMT), Phillips, Barcelona FC, and GNC (NYSE:GNC). Recently, it’s partnered with ASDA, a leading UK retailer under the Wal-Mart umbrella, as well as Bayer (OTCPK:BAYZF) and Cetaphil. As of March 2017, it operates 263 warehouses covering a gross floor area of 5.8 million square meters. GMV from the online direct sales business was RMB107.9 billion in the first quarter of 2017, up 42% from the first quarter of 2016. Net revenues from online direct sales increased by 40% in the first quarter of 2017 as compared to the first quarter of 2016. Fulfilled orders in the first quarter of 2017 were 477.1 million, an increase of 39% from 342.1 million in the same period in 2016. Fulfilled orders placed through mobile accounted for approximately 81% of total orders fulfilled in the first quarter of 2017, an increase of 56% compared to the same period in 2016.

    Online Marketplace – Third-party sellers offer products to customers and pay a commission to JD.com. They provide transaction processing and billing services on all orders on the online marketplace and leverage their own nationwide fulfillment infrastructu

  • [By SEEKINGALPHA.COM]

    We believe that the pharmaceutical sector has received too much negative attention. Despite the risks, a few companies offer good entry opportunities. In our previous article, we recommended Akorn. Today, we have analyzed Teva. We believe that the company is in a position to thrive in the generic market, and that it is priced very attractively. Yet, we don’t like management’s aggressive M&A strategy. We don’t like very aggressive companies since large acquisitions rarely create value for the shareholders. Contributors argue that Teva has overpaid for Actavis (its latest and largest acquisition) by at least $14B. This does not surprise us since most M&A deals are too expensive. Previous corruption issues add further doubts. Unfortunately, there is no amount of profit that can convince us to invest in a company where we do not like the management. We have sold our positions in Bayer (OTCPK:BAYZF) for similar reasons. We like Bayer, but we have sold our shares because of the Bayer-Monsanto (NYSE:MON) acquisition.

  • [By SEEKINGALPHA.COM]

    And this is pretty important ground. Hepatocellular carcinoma can be managed with local therapy (surgery, embolization, etc.), but at its most advanced stages, the options quickly start to thin out. For a decade, the only option in systemic therapy was Bayer’s (OTCPK:BAYZF) sorafenib. Recently, the effective systemic treatment armamentarium was doubled with the approval of regorafenib for second-line therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *